/XCRP

XCRP Stock - Xcorporeal, Inc.

Q: What is the analyst price target for XCRP?

Analyst price target information is not currently available for XCRP.

Q: What is XCRP's market cap?

Market capitalization information is not currently available for XCRP.

Healthcare|Medical - Specialties|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for XCRP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2004

FY2005

FY2006

FY2007

FY2008

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-416.93

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2008	FY2007	FY2006	FY2005	FY2004
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-31,892,793	$-18,257,381	$-99,185	$-177,631	$-107,348
Net Income	$-22,987,273	$-17,074,051	$5.33M	$-671,972	$-4,227,435
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-1.57	$-1.20	$4.43	$-0.56	$-3.57

Company Overview

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.

Frequently Asked Questions about XCRP

What is XCRP's current stock price?

Xcorporeal, Inc. (XCRP) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for XCRP?

No analyst price targets are currently available for this stock.

What sector is Xcorporeal, Inc. in?

Xcorporeal, Inc. operates in the Healthcare sector, specifically within the Medical - Specialties industry. The company is traded on the OTC exchange.

What is XCRP's market cap?

Xcorporeal, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does XCRP pay dividends?

No, Xcorporeal, Inc. does not currently pay a dividend to shareholders.